Connect with us

Hi, what are you looking for?

Pneumococcal Vaccine Market Size Growth Statistics Share Trends and Forecast 2028

The Global Pneumococcal Vaccine Market is poised to value USD 10722 million by 2028 end at a CAGR of 4.6% during the forecast period 2022 to 2028.

The most frequent type of pneumonia in adults is bacterial pneumonia, which can affect one or both lungs and can be brought on by bacteria, viruses, or fungi. Pneumonia causes inflammation around the lungs’ “sacs,” or alveoli, which leads to the alveoli filling with pus and making breathing difficult. Although adults and older people are more vulnerable to pneumococcal contaminations and even death, younger children are the population where pneumococcal diseases are most prevalent. The 13 different types of pneumococcal bacteria that cause lung infections are protected against by these vaccines. The introduction of novel pneumococcal vaccines, rising prevalence of pneumococcal contamination in the population, and increasing government support for raising awareness of pneumonia immunisation programmes are some of the key factors propelling the growth of the global pneumonia vaccine market. The development of the pneumococcal vaccines is however more expensive and requires longer development times, which is limiting the market’s global expansion. During the forecast period, it is also anticipated that the development of pneumonia vaccines based on proteins will open up opportunities for market expansion. Governments in various nations are implementing a range of initiatives to lessen the impact of pneumococcal diseases. For instance, the Social Action and Awareness to Successfully Neutralize Pneumonia initiative was launched by the Ministry of Health and Family Welfare (MoHFW) in India (SAANS). SAANA wants to reduce the prevalence of pneumonia by raising awareness of routine pneumococcal vaccination programmes. International organisations are also helping to achieve the goal. For instance, the Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea has been unveiled by the WHO and United Nations Children’s Emergency Fund (UNICEF) (GAPPD). GAPPD aims to safeguard, prevent, and treat children for diarrhoea and pneumonia.

The astute research report on Pneumococcal Vaccine market provides intricate details for analyzing appropriate parameters and valuable insights. The report offers extensive information about this business to help bring forth the growth potential of the market across various segments and provides the clients with a comprehensive analysis of factors like market size, market growth trends, competitive landscape, product utilization, regional growth prospects, and application potential, etc. The data provided in the report has been gathered from a wide variety of sources by using primary and secondary research. This Pneumococcal Vaccine research report also provides crucial insights into consumer behaviour, brand positioning, pricing analysis, and key player strategies. The market overview included in the Pneumococcal Vaccine research report incorporates critical factors procured from industry analysts, prominent players as well as trade and industrial organizations.

The report on Pneumococcal Vaccine market offers up-to-date information on the factors impeding the market growth which shall provide vendors with crucial insights into understanding the market dynamics thereby aiding the clients to sketch out a better business strategy. These factors will help them identify market growth opportunities. Furthermore, FutureWise research analysts provide timely assistance to their customers in understanding eccentric market parameters more effectively thereby leading to better decision-making.

Get a Sample of the Pneumococcal Vaccine Market Report @

The Pneumococcal Vaccine market research report is segmented –  by vaccine type, by dosage, by end-user, and by region. It also consists of insights regarding the revenue value and sales volume during the forecasted timeframe of 2022 to 2028.

Pneumococcal Vaccine Market Segmentation:

By Vaccine Type

Penumococcal Conjugate Vaccine
Pneumococcal Polysaccharide Vaccine

By Dosage

Single Dose Vial
Pre-Filled Syringe

By End-User

Children aged 2 to 10
Adulst aged 10  to 64
Geriatric aged more than 65

By Region

North America
Latin America
Middle East and Africa

Pneumococcal Vaccine Market Regional Analysis:

The report provides a complete evaluation of the potential amplification of the Pneumococcal Vaccine Market in pivotal geographic regions such as North America, Asia Pacific, Europe, Latin America and Middle East & Africa.

Competitive Landscape:                            

Some of the key market players are

Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline plc.
Sanofi Pasteur
China National Biotec Group
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd.
Panacea Biotec
Aurobindo Pharma

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide an extensive analysis of the global Pneumococcal Vaccine market by vaccine type, by dosage, by end-user, and by region

To carter complex data and information on the characteristics influencing the market growth (drivers, restraints, opportunities, and industry-specific restraints)

To predict and assess micro-markets and the overall market

To anticipate the market size, in key geographical regions (along with countries)— North America, Europe, Asia Pacific, Latin America and the Middle East and Africa

To estimate and inspect competitive landscape mapping- technological advancements, product launches, mergers and expansions

Flexible Delivery Model:

Our delivery model is flexible, so you can suggest changes to the content/scope as per your requirement

With purchase of any license of the report the customization Mobility Care offered is free of charge

You can directly forward your requirements/changes to the current table of content to:

About FutureWise Market Research:

We specialize in high-growth niche market research, offering flexibility, agility, and customized solutions for our clients. By providing our clients with market insights and consulting services, we ensure they stay on top of their industries for years to come.

FutureWise Market Research

Vinay T – Head of Business Development


UK: +44 141 628 9353 | USA: +1 347 709 4931


Written By

You may also like:

Tech & Science

Massive overseas and domestic investments offer Japan a chance to reclaim its tech crown.

Tech & Science

A part of the US surveillance program known as Section 702 allows intelligence agencies to conduct warrantless electronic monitoring of foreigners outside the United...


Roberto Cavalli dressed A-listers for decades and was known for his exotic animal prints and feather designs - Copyright AFP Brendan SmialowskiAlexandria SAGEItalian fashion...


Salman Rushdie, targeted for assassination since 1989 over his writing, had long wondered who would kill him.